A Study of the Serum Uric Acid Level as Prognostic Indicator in Acute Myocardial Infarction

Niraj Kumar1, Harender Kumar2, Vikas Kumar3

  • 1DNB Resident.

Insights

Serum uric acid levels are associated with the severity of heart failure in patients with acute myocardial infarction. Higher uric acid levels correlate with increased Killip class, indicating worse left ventricular function and higher mortality risk.

Area of Science:

  • Cardiology
  • Biochemistry

Background:

  • Coronary artery disease (CAD) is a leading cause of mortality.
  • Serum uric acid may serve as a prognostic marker for mortality in acute myocardial infarction (AMI).

Purpose of the Study:

  • To investigate the association between serum uric acid levels and Killip classes.
  • To determine the relationship between serum uric acid levels and ejection fraction in AMI patients.

Main Methods:

  • An observational prospective study enrolled 100 AMI patients.
  • Serum uric acid, Killip classification, and ejection fraction were assessed on days 0, 3, and 7.
  • Standard investigations including ECG and 2D-Echocardiogram were performed.

Main Results:

  • Serum uric acid levels significantly increased with higher Killip classes (I-IV) on all assessment days.
  • A significant negative correlation was observed between serum uric acid levels and ejection fraction on days 0, 3, and 7.
  • The majority of patients (68%) were over 50 years old.

Conclusions:

  • Elevated serum uric acid levels are significantly associated with higher Killip classes in AMI patients.
  • Higher serum uric acid levels indicate more severe left ventricular dysfunction and increased mortality risk.
  • Serum uric acid is a potential biomarker for assessing prognosis in acute myocardial infarction.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
155
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
711
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
476
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
618
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
306
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
218